A new, large study finds that African-Americans diagnosed with hepatitis C (HCV) respond better to treatment when the antiviral drug, ribavirin, is dosed based on weight rather than standardized.
http://www.hepatitis-central.com/mt/archives/2004/12/weightbased_tre.html